tiprankstipranks
Trending News
More News >
Novacyt S.A. (NVYTF)
:NVYTF
US Market

Novacyt (NVYTF) Earnings Dates, Call Summary & Reports

Compare
11 Followers

Earnings Data

Report Date
Sep 25, 2025
Before Open (Confirmed)
Period Ending
2025 (Q2)
Consensus EPS Forecast
Last Year’s EPS
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2024
Earnings Call Date:Apr 30, 2025|
% Change Since: 16.00%|
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive developments, including successful site consolidation and growth in key business segments, alongside significant financial losses and exceptional costs. While strategic initiatives and R&D investments show promise for future growth, the financial challenges and loss after tax weigh heavily on the current outlook.
Company Guidance -
Q4 2024
In the investor call, Novacyt provided guidance on several key metrics related to its operational and financial performance. The company successfully reduced its operating expenses (OpEx) from GBP 27 million to GBP 21 million, achieving GBP 3 million in additional savings from site consolidation and GBP 5 million from initial synergies. The gross profit for Fiscal Year 2024 was reported at GBP 32.1 million, with an underlying gross margin of 63%, meeting the company’s target of exceeding 60%. EBITDA loss was reduced by over 20% to GBP 9.1 million. Revenue has tripled over three years to GBP 19.6 million, driven by the Yourgene acquisition and strong growth in reproductive health, which saw a 26% increase year-on-year. The company also reported a net cash inflow of over GBP 7 million after resolving a dispute with DHSC, leading to a cash balance of GBP 30.5 million. Novacyt plans to invest GBP 2 million into R&D to drive organic growth, with the aim to self-fund the pathway to profitability.
Successful Site Consolidation
Novacyt consolidated their business footprint into a single Center of Excellence in Manchester, achieving GBP 3 million in savings on top of GBP 5 million from initial synergies.
Reproductive Health Growth
Reproductive health segment showed a 26% year-on-year growth, with significant contributions from cystic fibrosis and NIPT products.
Resolution of DHSC Dispute
Successfully resolved the Department of Health and Social Care dispute, resulting in a net cash inflow of over GBP 7 million.
Strong Gross Margin
Achieved an underlying gross margin of 63%, driven by strong sales in the PCR product range.
Reduction in EBITDA Loss
Reduced the EBITDA loss by over 20%, down to GBP 9.1 million.
Strategic Investment in R&D
Reinvested over GBP 2 million into R&D to drive organic growth, with expectations of incremental sales in H2.

Novacyt (NVYTF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NVYTF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Sep 25, 2025
2025 (Q2)
- / -
Apr 30, 2025
2024 (Q4)
- / -0.46
-0.371-24.16% (-0.09)
Sep 26, 2024
2024 (Q2)
- / -0.33
-0.153-117.04% (-0.18)
May 30, 2024
2023 (Q4)
- / -0.37
-0.317-16.79% (-0.05)
Sep 28, 2023
2023 (Q2)
- / -0.15
-0.001-13400.00% (-0.15)
Apr 27, 2023
2022 (Q4)
- / -0.32
0.056-671.43% (-0.37)
Sep 29, 2022
2022 (Q2)
- / >-0.01
-0.00250.00% (<+0.01)
Apr 28, 2022
2021 (Q4)
- / 0.06
Aug 18, 2021
2021 (Q2)
- / >-0.01
0.691-100.33% (-0.69)
Jun 22, 2021
2020 (Q4)
- / -
-0.102
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

NVYTF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 30, 2025
$0.50$0.53+6.00%
Sep 26, 2024
$0.92$0.84-8.70%
May 30, 2024
$0.50$0.500.00%
Sep 28, 2023
$0.79$0.72-8.86%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Novacyt S.A. (NVYTF) report earnings?
Novacyt S.A. (NVYTF) is schdueled to report earning on Sep 25, 2025, Before Open (Confirmed).
    What is Novacyt S.A. (NVYTF) earnings time?
    Novacyt S.A. (NVYTF) earnings time is at Sep 25, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NVYTF EPS forecast?
          Currently, no data Available
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis